Investigation of relationships between inflammation and brain disease in COPD

M. Bajaj (London, United Kingdom), S. Ruickbie (London, United Kingdom), D. Burrage (London, United Kingdom), C. Spilling (London, United Kingdom), J. Dodd (London, United Kingdom), A. Prasad (London, United Kingdom), P. Jones (London, United Kingdom), E. Baker (London, United Kingdom), T. Barrick (London, United Kingdom)

Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Session: Evaluation of COPD and various diseases by different imaging modalities
Session type: Poster Discussion
Number: 390
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bajaj (London, United Kingdom), S. Ruickbie (London, United Kingdom), D. Burrage (London, United Kingdom), C. Spilling (London, United Kingdom), J. Dodd (London, United Kingdom), A. Prasad (London, United Kingdom), P. Jones (London, United Kingdom), E. Baker (London, United Kingdom), T. Barrick (London, United Kingdom). Investigation of relationships between inflammation and brain disease in COPD. 390

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016


The relationship between bronchial inflammation and markers of disease progression in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 179s
Year: 2003

Relationship between markers of systemic inflammation and microstructural brain damage in COPD.
Source: International Congress 2019 – From the health effects of tobacco to the epidemiology of tobacco/electronic nicotine delivery system use
Year: 2019



Pathophysiological notions on the evolution of peripheral airways disease (PAD) to overt COPD
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010


Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006



Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007



Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012


The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011


Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011


Association between airway inflammation, disease control and lung function parameters in asthma
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019


Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006


Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012